BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 11797732)

  • 21. Is the FDA regulating the practice of medicine?
    Aicher RH
    Aesthet Surg J; 2013 Mar; 33(3):452-5. PubMed ID: 23515389
    [No Abstract]   [Full Text] [Related]  

  • 22. FDA drops legal battle to introduce graphic pictures on cigarette packs.
    Davies E
    BMJ; 2013 Mar; 346():f1913. PubMed ID: 23526043
    [No Abstract]   [Full Text] [Related]  

  • 23. The FDA's graphic tobacco warnings and the first amendment.
    Orentlicher D
    N Engl J Med; 2013 Jul; 369(3):204-6. PubMed ID: 23803137
    [No Abstract]   [Full Text] [Related]  

  • 24. FDA's proposed regulation of the sale and promotion of tobacco products to minors.
    Zieve AM
    Public Health Rep; 1996; 111(3):280-5. PubMed ID: 8643823
    [No Abstract]   [Full Text] [Related]  

  • 25. FDA marketing v. First Amendment: Washington Legal Foundation legal challenges to off-label policies may force unprecedented changes at FDA.
    Kamp J; Troy DE; Alexander E
    Food Drug Law J; 1999; 54(4):555-65. PubMed ID: 11824453
    [No Abstract]   [Full Text] [Related]  

  • 26. It's only skin deep: FDA regulation of skin care cosmetics claims.
    Liang BA; Hartman KM
    Cornell J Law Public Policy; 1999; 8(2):249-80. PubMed ID: 11010667
    [No Abstract]   [Full Text] [Related]  

  • 27. The butt stops here: the Tobacco Control Act's anti-smoking regulations run afoul of the First Amendment.
    Weatherby D; Day TR
    Albany Law Rev; 2012-2013; 76(1):121-65. PubMed ID: 23577376
    [No Abstract]   [Full Text] [Related]  

  • 28. Understanding government regulation of the marketing and advertising of medical devices, drugs, and biologics: the challenges of the Internet.
    Reichertz PS
    Food Drug Law J; 1997; 52(3):303-8. PubMed ID: 10343029
    [No Abstract]   [Full Text] [Related]  

  • 29. Regulation of dietary supplements: five years of DSHEA.
    Khatcheressian LA
    Food Drug Law J; 1999; 54(4):623-44. PubMed ID: 11824458
    [No Abstract]   [Full Text] [Related]  

  • 30. FDA's role in making exclusivity determinations.
    Dickinson EH
    Food Drug Law J; 1999; 54(2):195-203. PubMed ID: 11758573
    [No Abstract]   [Full Text] [Related]  

  • 31. New challenges for medical product promotion and its regulation.
    Pines WL
    Food Drug Law J; 1997; 52(1):61-5. PubMed ID: 10346710
    [No Abstract]   [Full Text] [Related]  

  • 32. Medicine goes Madison Avenue: an evaluation of the effect of direct-to-consumer pharmaceutical advertising on the learned intermediary doctrine.
    Allen MC
    Spec Law Dig Health Care Law; 1998 Dec; (236):9-29. PubMed ID: 10187553
    [No Abstract]   [Full Text] [Related]  

  • 33. Cowboys, camels, and the First Amendment--the FDA's restrictions on tobacco advertising.
    Annas GJ
    N Engl J Med; 1996 Dec; 335(23):1779-83. PubMed ID: 8929272
    [No Abstract]   [Full Text] [Related]  

  • 34. How should FDA regulate prescription drug promotion on the Internet?
    Opderbeck DW
    Food Drug Law J; 1998; 53(1):47-61. PubMed ID: 11795336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The "natural" aversion: the FDA's reluctance to define a leading food-industry marketing claim, and the pressing need for a workable rule.
    Farris AL
    Food Drug Law J; 2010; 65(2):403-24, iv. PubMed ID: 24475548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prescription drug marketing act: a solution in search of a problem?
    Angarola RT; Beach JE
    Food Drug Law J; 1996; 51(1):21-55. PubMed ID: 11794352
    [No Abstract]   [Full Text] [Related]  

  • 37. Regulation of cosmetics that are also drugs.
    Greff JA
    Food Drug Law J; 1996; 51(2):243-72. PubMed ID: 11820201
    [No Abstract]   [Full Text] [Related]  

  • 38. The FDA's regulation of pharmaceutical communications in the context of managed care: a suggested approach.
    Kuhlik BN
    Food Drug Law J; 1995; 50(1):23-48. PubMed ID: 10342984
    [No Abstract]   [Full Text] [Related]  

  • 39. From herbal Prozac to Mark McGwire's tonic: how the Dietary Supplement Health and Education Act changed the regulatory landscape for health products.
    Kaczka KA
    J Contemp Health Law Policy; 2000; 16(2):463-99. PubMed ID: 10970182
    [No Abstract]   [Full Text] [Related]  

  • 40. Prescription for the Orphan Drug Act: the impact of the FDA's 1992 regulations and the latest congressional proposals for reform.
    Clissold DB
    Food Drug Law J; 1995; 50(1):125-47. PubMed ID: 10342989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.